{
    "2018-01-25": [
        [
            {
                "time": "",
                "original_text": "速读社丨上海医药子公司孙公司对簿公堂 美国砸下1.9亿美元推动基因编辑疗法进程",
                "features": {
                    "keywords": [
                        "上海医药",
                        "子公司",
                        "法律纠纷",
                        "美国",
                        "基因编辑",
                        "疗法",
                        "1.9亿美元"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}